We have used autaptic hippocampal neurons cultured from fmr1 knockout mice to further explore the interaction between endocannabinoid signaling and FMRP. These neurons express several robust forms of retrograde endocannabinoid signaling including depolarization induced suppression of excitation (DSE) and a metabotropic form (MSE) that results from Group I mGluR activation. We now report that young fmr1 neurons exhibit considerably enhanced DSE, likely via increased production of 2-AG, rather than enhanced mGluR-MSE. We find that depolarizations as brief as 50 ms, which do not ordinarily produce DSE, routinely inhibited glutamate release. Furthermore, as neuronal cultures mature, CB 1 -receptor signaling strongly desensitizes. Our results suggest that loss of FMRP broadly affects the endocannabinoid signaling system, possibly through local 2-AG over production. Furthermore, the net effect of the loss of FMRP may actually be diminished cannabinoid signaling due to receptor desensitization as an adaptation to 2-AG overproduction.
Introduction
Fragile X Syndrome (FXS) is the most common heritable form of mental retardation, arising from an expanded and hypermethylated non-coding trinucleotide repeat of the FMR gene (Verkerk et al., 1991) . This leads to a deficiency of fragile X mental retardation protein (FMRP), an RNA binding protein. In addition to significant mental retardation, FXS may be associated with neurological abnormalities including seizures (Kerbeshian et al., 1984) . Mutations in this gene are linked to enhancement of metabotropic glutamate receptor or (mGluR) Group I signaling (Huber et al., 2002) a change that may be due to increased mGluR protein synthesis (Bear et al., 2004; Dolen et al., 2007; Pfeiffer and Huber, 2006) . The evidence for an mGluR Group I link to FXS gave rise to an "mGluR theory" of FXS (Bear et al., 2004) .
The cannabinoid signaling system includes cannabinoid CB 1 receptors that are the target of exogenous phytocannabinoids such as Δ 9 -THC (Gaoni and Mechoulam, 1964; Matsuda et al., 1990) , the chief psychoactive ingredient in marijuana and hashish. This signaling system also includes endogenous cannabinoids, including 2-arachidonoyl glycerol (Stella et al., 1997), a lipid messenger, and the enzymes to produce and break down this messenger (Bisogno et al., 2003; Dinh et al., 2002) . Functionally, this CB 1 -based signaling system has been shown to serve as a retrograde signaling mechanism in many neurons throughout the CNS (Kano et al., 2009; Wilson and Nicoll, 2001 ). 2-AG is produced in response to activation of diacylglycerol lipases in dendrites, either via depolarization (increasing intracellular calcium) or activation of metabotropic receptors (Bisogno et al., 2003) . When targeting excitatory neurons, the former form of plasticity is known as depolarization induced suppression of excitation (DSE) whereas the latter is metabotropic suppression of excitation (MSE). The consequence of DSE or MSE in glutamatergic neurons is an inhibition of glutamate release. Analogous processes targeting inhibitory neurons are referred to as DSI/MSI. DSE/ DSI typically lasts for tens of seconds and occurs via inhibition of presynaptic calcium channels. MSE/I is driven by post-synaptic G q -coupled receptor activation of phospholipase C beta (PLCβ). The best-studied Abbreviations: DSE, depolarization-induced suppression of excitation; FXS, Fragile X Syndrome; mGluR, metabotropic glutamate receptor; FMRP, fragile X mental retardation protein; MSE, metabotropic suppression of excitation; 2-AG, 2-arachidonoyl glycerol; EPSC, excitatory postsynaptic current; DHPG, dihydroxyphenyl glycine; MPEP, 2-methyl-6-(phenylethynyl)-pyridine; CPA, cyclopentyladenosine; LTD, long-term depression. ☆ The authors declare no competing financial interests.
